121 related articles for article (PubMed ID: 9608642)
1. Predominant p53 G-->A transition mutation and enhanced cell proliferation in uterine sarcomas of CBA mice treated with 1,2-dimethylhydrazine.
Trukhanova LS; Hong HH; Sills RC; Bowser AD; Gaul B; Boorman GA; Turusov VS; Devereux TR; Dixon D
Toxicol Pathol; 1998; 26(3):367-74. PubMed ID: 9608642
[TBL] [Abstract][Full Text] [Related]
2. p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas.
Zhang Z; Li J; Lantry LE; Wang Y; Wiseman RW; Lubet RA; You M
Cancer Res; 2002 Jun; 62(11):3024-9. PubMed ID: 12036908
[TBL] [Abstract][Full Text] [Related]
3. Uterine sarcomas in CBA mice induced by combined treatment with 1,2-dimethylhydrazine and estradiol dipropionate. Light and electron microscopy.
Turusov VS; Raikhlin NT; Smirnova EA; Trukhanova LS
Exp Toxicol Pathol; 1993 May; 45(2-3):161-6. PubMed ID: 8329867
[TBL] [Abstract][Full Text] [Related]
4. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.
Watanabe H; Shimokado K; Asahara T; Dohi K; Niwa O
Jpn J Cancer Res; 1999 Jan; 90(1):40-7. PubMed ID: 10076563
[TBL] [Abstract][Full Text] [Related]
6. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
Stefanou DG; Nonni AV; Agnantis NJ; Athanassiadou SE; Briassoulis E; Pavlidis N
Anticancer Res; 1998; 18(6B):4673-81. PubMed ID: 9891539
[TBL] [Abstract][Full Text] [Related]
7. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
Tsuda H; Hirohashi S
Jpn J Cancer Res; 1992 Nov; 83(11):1184-91. PubMed ID: 1336492
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatous lesions in CBA female mice treated with 1,2-dimethylhydrazine: independent primaries or metastases?
Trukhanova LS; Turusov VS
Clin Exp Metastasis; 1995 Sep; 13(5):389-95. PubMed ID: 7641423
[TBL] [Abstract][Full Text] [Related]
9. Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea.
Mitsumori K; Onodera H; Shimo T; Yasuhara K; Takagi H; Koujitani T; Hirose M; Maruyama C; Wakana S
Carcinogenesis; 2000 May; 21(5):1039-42. PubMed ID: 10783330
[TBL] [Abstract][Full Text] [Related]
10. [Effect of neonatal androgenization on uterine sarcomagenesis induced by 1,2-dimethylhydrazine in female CBA mice].
Smirnova IO; Turusov VS
Biull Eksp Biol Med; 1983 Oct; 96(10):91-2. PubMed ID: 6626740
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas.
Hall KL; Teneriello MG; Taylor RR; Lemon S; Ebina M; Linnoila RI; Norris JH; Park RC; Birrer MJ
Gynecol Oncol; 1997 May; 65(2):330-5. PubMed ID: 9159347
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of uterine sarcoma induced in mice in terms of the two-staged development of tumors].
Turusov VS; Linnik AB; Morozova OV; Parfenov IuD
Eksp Onkol; 1984; 6(2):20-3. PubMed ID: 6510329
[TBL] [Abstract][Full Text] [Related]
14. [Effect of 1,2-dimethylhydrazine on the estrous cycle in different strains of mice].
Trukhanova LS
Eksp Onkol; 1986; 8(6):21-4. PubMed ID: 3803285
[TBL] [Abstract][Full Text] [Related]
15. Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
Szollosi Z; Nemeth T; Egervari K; Nemes Z
Pathol Res Pract; 2005; 201(5):369-77. PubMed ID: 16047946
[TBL] [Abstract][Full Text] [Related]
16. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
17. How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone?
Taubert H; Berger D; Hinze R; Meye A; Würl P; Hogendoorn PC; Holzhausen HJ; Schmidt H; Rath FW
Cancer Lett; 1998 Jan; 123(2):147-51. PubMed ID: 9489481
[TBL] [Abstract][Full Text] [Related]
18. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
19. [Effect of estradiol dipropionate in various doses on induced uterine sarcomagenesis in mice].
Morozova OV; Parfenov IuD
Eksp Onkol; 1986; 8(3):31-2. PubMed ID: 3720638
[TBL] [Abstract][Full Text] [Related]
20. p53 immunohistochemical analysis of fusion-positive uterine sarcomas.
Mohammad N; Stewart CJR; Chiang S; Turashvili G; Dickson BC; Ng TL; Köbel M; McCluggage WG; Croce S; Lee CH
Histopathology; 2021 May; 78(6):805-813. PubMed ID: 33118176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
